Cathay Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	5,347	5,390	6,295	9,629
Trading Asset Securities	-	0.47	0.47	0.47	0.47
Cash & Short-Term Investments	9,008	5,347	5,391	6,295	9,629
Cash Growth	68.47%	-0.81%	-14.37%	-34.62%	36.78%
Accounts Receivable	-	459.88	385.52	463.56	275.22
Other Receivables	-	10.56	10.35	11.79	6.58
Receivables	-	470.43	395.88	475.35	281.8
Inventory	-	1,181	1,466	1,574	1,185
Prepaid Expenses	-	7.29	10.57	-	-
Other Current Assets	-	381.4	307.18	131.44	298.68
Total Current Assets	-	7,387	7,571	8,475	11,395
Property, Plant & Equipment	-	9,849	9,376	6,670	2,969
Long-Term Investments	-	133.78	142.73	49.51	53.21
Other Intangible Assets	-	685.04	703.85	777.87	768.46
Long-Term Deferred Tax Assets	-	210.37	158.88	88.28	52.2
Long-Term Deferred Charges	-	6.42	4.98	7.17	9.58
Other Long-Term Assets	-	750.4	876.48	1,759	938.51
Total Assets	-	19,021	18,833	17,827	16,185
Accounts Payable	-	135.44	167.85	240.08	248.83
Accrued Expenses	-	30.32	21.54	32.47	42.34
Short-Term Debt	-	1,247	746.25	161.47	743.51
Current Portion of Long-Term Debt	-	37.17	784.37	5.38	-
Current Income Taxes Payable	-	32.94	55.54	30.7	45.4
Current Unearned Revenue	-	35.81	10.48	17.81	14.64
Other Current Liabilities	-	1,399	1,624	936.28	123.01
Total Current Liabilities	-	2,918	3,410	1,424	1,218
Long-Term Debt	-	613.26	245.33	960.5	-
Long-Term Unearned Revenue	-	389.29	405.18	404.39	293.03
Total Liabilities	-	3,920	4,060	2,789	1,511
Common Stock	-	583.38	583.38	583.28	416.68
Additional Paid-In Capital	-	8,520	8,526	8,540	8,688
Retained Earnings	-	2,546	2,167	1,905	1,539
Treasury Stock	-	-155.13	-126.19	-94.67	-
Comprehensive Income & Other	-	12.77	14.45	14.69	8.23
Total Common Equity	17,598	11,507	11,164	10,949	10,652
Minority Interest	-	3,594	3,609	4,089	4,022
Shareholders' Equity	21,217	15,101	14,773	15,038	14,674
Total Liabilities & Equity	-	19,021	18,833	17,827	16,185
Total Debt	279.23	1,897	1,776	1,127	743.51
Net Cash (Debt)	8,729	3,450	3,615	5,168	8,886
Net Cash Growth	153.02%	-4.56%	-30.05%	-41.84%	26.22%
Net Cash Per Share	12.81	5.93	6.21	8.87	15.24
Filing Date Shares Outstanding	708.42	718.95	581.32	582.15	583.35
Total Common Shares Outstanding	708.42	582.75	581.68	582.15	583.35
Working Capital	-	4,469	4,161	7,051	10,177
Book Value Per Share	24.98	19.75	19.19	18.81	18.26
Tangible Book Value	16,913	10,822	10,460	10,171	9,883
Tangible Book Value Per Share	24.01	18.57	17.98	17.47	16.94
Buildings	-	1,958	1,815	1,357	988.18
Machinery	-	3,330	3,216	2,979	1,807
Construction In Progress	-	5,949	5,443	3,164	758.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.